Hyosang (Mark) Kim

Associate, New York



Hyosang (Mark) Kim is an associate in the Technology Transactions Practice, within the Firm's Global M&A Group and Global IP Group. Mark focuses on transactional matters involving the development, acquisition, transfer, and licensing of intellectual property and information technology in a variety of sectors.

Prior to focusing on transactional work, Mark litigated complex patent and technology-related disputes with an emphasis on pharmaceuticals and healthcare.

Mark earned a Bachelor of Arts, with distinction, in Biology from the University of Virginia and received his law degree, with pro bono distinction, from Stanford Law School, where he served on the Stanford Technology Law Review.

Mark is admitted to the New York State Bar and is also admitted to practice before the United States Patent and Trademark Office.

Bars and Courts
New York State Bar
US Patent and Trademark Office
Stanford Law School
University of Virginia


Recent matters include representation of:

Roche Diagnostics Corp. in the sale of 100% of the issued and outstanding stock of Roche Health Solutions Inc. to CardioNet, LLC, a wholly owned subsidiary of BioTelemetry, Inc.

Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture, and commercialization of innovative diagnostic imaging agents and products, in its offer to acquire Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC), an oncology company developing innovative medicines and artificial intelligence to find, fight, and follow cancer, in an all-stock transaction.

Landcadia Holdings II, Inc. (NASDAQ: LCA), a blank check company, on its cash and stock acquisition of Golden Nugget Online Gaming, Inc. (GNOG), one of the nation's leading online casinos, from Landry's Fertitta LLC, part of the Landry's group of restaurant and hospitality businesses.

Itron Inc. in the sale of its subsidiaries comprising its manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell).

Morgan Stanley Infrastructure Inc. in its acquisition of Seven Seas Water Corp., AquaVenture Holdings Inc., and AquaVenture Holdings Curacao N.V., a multinational developer, owner and operator of water production and wastewater treatment plants and businesses, from AI Aqua (Luxembourg) S.a.r.l, a company owned by Advent International Corporation.

Harvest Partners in an investment in MRI Software, a leading provider of real estate management software solutions globally.

GPA Global, a portfolio company of EQT Partners AB and a leader in premium packaging, sustainable packaging, and display solutions based in China, on its acquisition of Hub Folding Box, a printing and packaging powerhouse with one of the most technologically advanced facilities in North America.

Advance Stores Company, Inc., a wholly owned subsidiary of Advance Auto Parts, Inc. (a leading automotive parts provider), in its acquisition of the DieHard brand from Transform Holdco LLC, a leading integrated retailer, in exchange for cash consideration.

Dominus Capital, L.P. in its acquisition of Surface Preparation Technologies, LLC, the country's leading provider of rumble strips and related roadway safety services.

Ichnos Sciences S.A. (formerly known as Glenmark Pharmaceuticals S.A.) in its biologic drug substance supply arrangements for ISB 830 (an antibody in development as a potential treatment for autoimmune diseases) with Samsung Biologics.